Strides Pharma Science Ltd and Orbicular Pharmaceutical Technologies Pvt Ltd today informed that they have entered into a strategic partnership to develop, manufacture and commercialize nasal sprays for the global markets.
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it has ended its AKS-452 licensing, manufacturing, and commercialization agreement with Stelis Biopharma Limited, an arm of Strides Pharma Science Ltd.
Strides Pharma Science Ltd has announced that the USFDA today issued an Establishment Inspection Report in relation to the inspection of the Company s flagship facility in Bangalore, India.
Get latest articles and stories on Latest News at LatestLY. The government is taking steps to produce "high value pharmaceuticals" in the country to reduce import dependency for such critical articles, Union Minister Mansukh Mandaviya said on Tuesday. Latest News | Govt Focussing on Production of High Value Pharmaceuticals: Mansukh Mandaviya.
The Board of Directors of Strides Pharma Science Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.